Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.

Chew A, Salama P, Robbshaw A, Klopcic B, Zeps N, Platell C, Lawrance IC.

PLoS One. 2011;6(7):e22047. doi: 10.1371/journal.pone.0022047. Epub 2011 Jul 26.

2.

OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.

Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA.

Oncotarget. 2015 Nov 10;6(35):37588-99. doi: 10.18632/oncotarget.5940.

3.

Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.

Gao S, Tibiche C, Zou J, Zaman N, Trifiro M, O'Connor-McCourt M, Wang E.

JAMA Oncol. 2016 Jan;2(1):37-45. doi: 10.1001/jamaoncol.2015.3413.

PMID:
26502222
4.

Increased number of forkhead box P3+ tumor-infiltrating lymphocytes correlates with high preoperative albumin level and better survival in patients with stage II or III colorectal cancer.

Wang DL, Liu YY, Gu YL, Qin Y, Ji HF, Wu LH, Qi N, Su D, Huang SH, Zhang YQ.

Tumour Biol. 2015 Jul;36(7):5407-14. doi: 10.1007/s13277-015-3206-8. Epub 2015 Feb 20.

PMID:
25697896
5.

Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B.

J Clin Oncol. 2009 Jan 10;27(2):186-92. doi: 10.1200/JCO.2008.18.7229. Epub 2008 Dec 8.

PMID:
19064967
6.

Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.

Yoshimura T, Nagahara M, Kuo C, Turner RR, Soon-Shiong P, Hoon DS.

Epigenetics. 2011 Aug;6(8):1001-11. doi: 10.4161/epi.6.8.16063. Epub 2011 Aug 1.

PMID:
21725199
7.

High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.

Hanke T, Melling N, Simon R, Sauter G, Bokemeyer C, Lebok P, Terracciano LM, Izbicki JR, Marx AH.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8227-35. eCollection 2015.

8.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
9.

LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.

Stanisavljević L, Myklebust MP, Leh S, Dahl O.

Acta Oncol. 2016 Dec;55(12):1425-1433. Epub 2016 Jul 20.

PMID:
27435662
10.

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J.

J Clin Oncol. 2009 Dec 10;27(35):5944-51. doi: 10.1200/JCO.2008.19.6147. Epub 2009 Oct 26.

PMID:
19858404
11.

Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.

Kim Y, Bae JM, Li G, Cho NY, Kang GH.

PLoS One. 2015 Apr 15;10(4):e0122183. doi: 10.1371/journal.pone.0122183. eCollection 2015.

12.

CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival.

Koelzer VH, Lugli A, Dawson H, Hädrich M, Berger MD, Borner M, Mallaev M, Galván JA, Amsler J, Schnüriger B, Zlobec I, Inderbitzin D.

J Transl Med. 2014 Mar 29;12:81. doi: 10.1186/1479-5876-12-81.

13.

Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.

Miyashita M, Sasano H, Tamaki K, Hirakawa H, Takahashi Y, Nakagawa S, Watanabe G, Tada H, Suzuki A, Ohuchi N, Ishida T.

Breast Cancer Res. 2015 Sep 4;17:124. doi: 10.1186/s13058-015-0632-x.

14.

[The effects of CEACAM6 and FOXP3 on tumor infiltrating lymphocytes and prognosis in patients with pancreatic cancer].

Zhang K, Liu Y, Jin C, Gu D, Xia T, Ye J.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Aug;31(8):1103-7. Chinese.

PMID:
26271985
15.

VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.

Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjänen S, Syrjänen K, Collan Y, Pyrhönen S.

Anticancer Res. 2008 Nov-Dec;28(6B):3865-70.

16.

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma.

Buhmeida A, Bendardaf R, Hilska M, Laine J, Collan Y, Laato M, Syrjänen K, Pyrhönen S.

Ann Oncol. 2009 Jul;20(7):1230-5. doi: 10.1093/annonc/mdn783. Epub 2009 Mar 10.

PMID:
19276398
17.

Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.

Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N.

Mod Pathol. 2014 Jun;27(6):906-15. doi: 10.1038/modpathol.2013.204. Epub 2013 Dec 6.

18.

FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer.

Liu Y, Xia T, Jin C, Gu D, Yu J, Shi W, Zhang KE, Zhang L, Ye J, Li L.

Oncol Lett. 2016 Jun;11(6):3693-3701. Epub 2016 Apr 14.

19.

High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.

Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L.

Int J Cancer. 2010 Jun 1;126(11):2635-43. doi: 10.1002/ijc.24989.

20.

Clinical impact of tumor-infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis.

Lee WS, Kang M, Baek JH, Lee JI, Ha SY.

Ann Surg Oncol. 2013 Feb;20(2):697-702. doi: 10.1245/s10434-012-2752-1. Epub 2012 Dec 6.

PMID:
23224827

Supplemental Content

Support Center